Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CLASRP | CTRPv2 | pan-cancer | AAC | 0.094 | 0.03 |
mRNA | CBX7 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
mRNA | SAP25 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
mRNA | GPR65 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
mRNA | WNT8B | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
mRNA | SFRP5 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
mRNA | RP11-295P9.13 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
mRNA | SCN3B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
mRNA | GZMB | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
mRNA | MRPL4 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |